Qube Research & Technologies (QRT)
FLXN

Qube Research & Technologies (QRT)’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,333
Closed -$155K – 3002
2021
Q1 		$155K Buy
+17,333
New +$199K ﹤0.01% 1692
2020
Q4 		– Sell
-20,677
Closed -$215K – 2336
2020
Q3 		$215K Buy
+20,677
New +$253K ﹤0.01% 1368

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FLXN Position: Q2 2021 in Review

Qube Research & Technologies (QRT) sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2021, closing a stake of 17,333 shares — an estimated $155K sold.

Qube Research & Technologies (QRT) first reported a position in FLXN in Q3 2020 and held it in 2 quarters. The position peaked at $215K in Q3 2020. 140 funds tracked by Wall St. Rank hold FLXN as of Q2 2021.

  • Qube Research & Technologies (QRT) reported no remaining Flexion Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 17,333 Flexion Therapeutics, Inc. shares in Q2 2021, an estimated $155K.
  • Qube Research & Technologies (QRT) first reported a position in Flexion Therapeutics, Inc. in Q3 2020 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Flexion Therapeutics, Inc. position peaked at $215K in Q3 2020.
  • 140 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2021, filed 13 Aug 2021.